Personalized management of platelet transfusion refractoriness: risk factors, cross-matching, and IVIG strategies
Jixin Li, Linting Wang, Yi Qin, Yingyin Liang, Piao Lv, Yuan Yao, Xinxin Fan, Huayou Zhou · 2026
Read Personalized management of platelet transfusion refractoriness: risk factors, cross-matching, and IVIG strategies by Jixin Li, Linting Wang, Yi Qin, Yingyin Liang, Piao Lv, Yuan Yao, Xinxin Fan, Huayou Zhou (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13630665.txt.
Description
Some blood patients stop responding to platelet transfusions, a problem that leaves them at risk of bleeding. Jixin Li and co-authors review 144 such patients at a Chinese hospital in this 2026 study, covering more than thirteen hundred transfusion episodes and four treatment plans.
Being female was the strongest predictor of forming the antibodies behind the problem. Among patients with antibodies, matched platelets raised blood counts best, and adding immune protein therapy to random platelets also helped. Among patients without antibodies, no plan beat the others. The results support testing for antibodies first, then matching the treatment plan to the patient.
Catalog record
| CREATOR | Jixin Li, Linting Wang, Yi Qin, Yingyin Liang, Piao Lv, Yuan Yao, Xinxin Fan, Huayou Zhou |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 61 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |